Physician profile
Yvette Kimble
NPI 1598201048
$4,251.85
in general payments reported to CMS, 2019-2025
21 companies · $2,121 in 2025
The $2,121 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $165 · 2023: $507 · 2024: $1,334 · 2025: $2,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,942 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,942.24 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $510.33 | 2023-2025 | |
| Gilead Sciences, INC. | $488.12 | 2024-2025 | Livdelzi, Epclusa |
| Amgen INC. | $476.22 | 2024-2025 | Evenity |
| Novo Nordisk INC | $336.00 | 2024 | Wegovy |
| Madrigal Pharmaceuticals | $275.17 | 2025 | Rezdiffra |
| Otsuka America Pharmaceutical, INC. | $240.89 | 2023-2024 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $205.67 | 2021-2024 | Airsupra |
| Grifols USA, LLC | $191.02 | 2022-2023 | Prolastin-C Liquid |
| Coloplast Corp | $169.78 | 2025 | |
| Insulet Corporation | $169.25 | 2025 | Omnipod |
| Boston Scientific Corporation | $145.06 | 2025 | Apollo Esg System |
| Smith+Nephew, INC. | $130.34 | 2022-2023 | Collagenase Santyl |
| Neurelis, INC. | $124.94 | 2024 | Valtoco |
| Acadia Pharmaceuticals INC | $119.18 | 2025 | Nuplazid |
| Idorsia Pharmaceuticals US INC | $118.85 | 2025 | Tryvio |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $116.73 | 2023 | Mounjaro |
| Inspire Medical Systems, INC. | $110.52 | 2025 | Inspire |
| Exact Sciences Corporation | $107.10 | 2025 | The Cologuard Plus Collection Kit |
| Braeburn INC. | $104.22 | 2025 | Brixadi |
| E.R. Squibb & Sons, L.L.C. | $92.46 | 2025 | Cobenfy |
| Tactile Systems Technology INC | $20.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yvette Kimble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.